サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：整形外科再生手術用製品の市場規模、シェア、動向分析レポート：製品別、最終用途別、用途別、地域別、セグメント予測、2023年～2030年
市場調査レポート
商品コード
1321447

整形外科再生手術用製品の市場規模、シェア、動向分析レポート：製品別、最終用途別、用途別、地域別、セグメント予測、2023年～2030年

Orthopedic Regenerative Surgical Products Market Size, Share & Trends Analysis Report By Product (Allografts, Viscosupplements), By End-use (Hospitals, ASCs), By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
整形外科再生手術用製品の市場規模、シェア、動向分析レポート：製品別、最終用途別、用途別、地域別、セグメント予測、2023年～2030年
出版日: 2023年07月31日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

整形外科再生手術用製品市場の成長と動向

Grand View Research社の最新レポートによると、整形外科再生手術用製品の世界市場規模は2030年までに56億3,000万米ドルに達すると予測されています。

同市場は、2023年から2030年にかけて4.0％の魅力的なCAGRで成長すると予測されています。市場成長を後押しする主な要因には、高齢者人口の増加、整形外科治療＆処置の容易な入手可能性、技術の進歩などがあります。例えば、整形外科疾患の一つである変形性関節症は、老人人口（70歳以上）における慢性障害の主要因と考えられてきました。COVID-19の大流行時には、病院・診療所における慢性疾患の患者数の減少、マーケティング・販売活動の停止、選択手術の延期、社会的距離の遠ざけ方、戸締まりプロトコルのため、製品需要が減少しました。

例えば、アニカ・セラピューティクス社は、パンデミックの影響で臨床試験の患者登録に課題があり、同社の業績と収益に悪影響を及ぼしました。しかし、同社はパンデミック後に選択的手術が再開されたため、業績と事業を回復させました。米国疾病予防管理センター（CDC）によると、米国では2040年までに人口の26％にあたる約7,800万人の成人が関節炎と診断されると予測されています。関節炎のリスクは年齢とともに増加し、女性に多いことが分かっています。もう一つの危険因子は肥満です。CDCによると、米国における肥満の有病率は2017年から2018年にかけて約42.4％と推定されています。したがって、整形外科疾患の有病率の増加、高齢化人口の増加＆肥満症例が市場成長を促進すると予想されます。整形外科の再生手術に使用される製品は、痛風、関節痛、線維筋痛症、関節欠損、変形性関節症、人工関節置換術、外傷など、幅広い用途に使用されています。

このことも市場の成長に寄与すると予想されます。同市場の主要企業は、疾患による疼痛緩和のための新たな再生ソリューションを導入するための研究開発プロジェクトなど、いくつかの戦略的取り組みを行っています。例えば、2021年3月、Amniox Medical, Inc.は、臍帯と凍結保存羊膜からなる治験薬（IND）TTAX03-を使用して、小面体関節変形性関節症の痛みを緩和するための投与試験を進めるためのFDA認可を取得しました。例えば、Zimmer Biometは、InterGro DBM、PrimaGen Advanced allograft、PlatFORM bioresorbable bone graft substituteなどの合成整形外科用再生製品や移植片の幅広いポートフォリオを提供しています。

整形外科再生手術用製品市場レポートハイライト

  • 変形性関節症などの整形外科疾患の有病率の高さ、市場における製品の入手可能性の増加により、粘液サプリメント分野は2022年に約42.59%の最大市場シェアを占めました。
  • 同種移植片分野は、同種移植片の利用が増加していることから、予測期間中のCAGRは4.1%と予測されています。
  • 関節再建分野は、関節再建における再生ソリューションの採用が増加しているため、2022年の用途別セグメントで35.66%の最大収益シェアを占めました。
  • 軟骨・腱修復セグメントは、高齢者患者やスポーツ医学における用途の増加により、予測期間中に4.2%のCAGRで最も急速に成長すると予測されます。
  • ほとんどの整形外科治療は病院で行われるため、病院の最終用途分野が市場を独占し、2022年には約49.04％の最大収益シェアを占めました。
  • 外来手術センター（ASC）セグメントは、予測期間中に4.1%という最も速いCAGRを示すと予想されています。
  • 市場の主なプレーヤーは、製品開発と発売、研究開発、地域拡大、流通網の拡大など、さまざまな戦略的取り組みを行っています。
  • 2021年1月、Stryker社はセンサー技術と筋骨格系ケアを専門とする非公開会社OrthoSensor, Inc.を買収しました。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 調査手法
  • 調査の仮定
  • 情報調達
  • 情報またはデータ分析
  • 市場の形成と検証
  • モデル詳細
  • 二次情報のリスト

第2章 エグゼクティブサマリー

第3章 整形外科再生手術用製品市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場分析
    • 付随市場の見通し
  • 整形外科再生手術用製品市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
    • 市場機会分析
    • 市場課題の分析
  • 普及と成長の見通しマッピング、2022年
  • SWOT分析、要因別（政治・法律、経済・技術）
    • 政治と法律
    • 経済情勢
    • テクノロジーの情勢
  • 整形外科再生手術用製品市場分析ツール：ポーター
    • 供給企業の交渉力：低～中程度
    • 買い手の交渉力：中程度
    • 代替品の脅威：高
  • 規制の枠組み
    • FDAに関する考慮事項
    • 償還の枠組み
    • Hcpcsコーディング
  • 技術トレンド分析
  • 製品パイプライン分析
  • 変形性関節症の有病率（2018年から2030年）

第4章 整形外科再生手術用製品市場：COVID-19の影響分析

  • COVID-19感染症の影響分析
    • 病気の有病率の分析
    • 現在の影響分析
    • 将来の影響分析
    • 市場参入企業への影響

第5章 整形外科再生手術用製品市場：セグメント分析、製品別、2018年～2030年

  • 製品市場シェア分析、2022年および2030年
  • 整形外科再生手術用製品市場、製品別、2018年から2030年
  • 同種移植片
  • 合成
  • 細胞ベース
  • 粘性サプリメント

第6章 整形外科再生手術用製品市場分析、用途別、2018～2030年（収益）

  • 用途市場シェア分析、2022年および2030年
  • 整形外科再生手術用製品市場、用途別、2018年から2030年
  • 整形外科的疼痛管理
  • トラウマの修復
  • 軟骨と腱の修復
  • 関節再建
  • その他

第7章 整形外科再生手術用製品市場：セグメント分析、エンドユース別、2018年～2030年

  • エンドユース市場シェア分析、2022年および2030年
  • 整形外科再生手術用製品市場、エンドユース別、2018年から2030年
  • 病院
  • 外来手術センター
  • その他

第8章 整形外科再生手術用製品市場：地域市場分析2018年～2030年

  • 地域市場シェア分析、2022年および2030年
  • 地域市場のスナップショット
  • 北米
    • 北米の整形外科再生手術用製品市場推計・予測、2018年から2030年
    • 米国
    • カナダ
  • 欧州
    • 欧州の整形外科再生手術用製品市場推計・予測、2018年から2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • アジア太平洋地域の整形外科再生手術用製品市場推計・予測、2018年から2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカの整形外科再生手術用製品市場、2018年～2030年
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • MEA整形外科再生手術用製品市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア

第9章 整形外科再生手術用製品市場-企業プロファイル

  • 企業プロファイル
    • Baxter
    • Zimmer Biomet
    • Stryker
    • Smith+Nephew
    • Allosource
    • Amniox Medical, Inc.
    • Anika Therapeutics, Inc.
    • Vericel Corporation
    • Vsy Biotechnology Gmbh
    • Aptissen SA
    • Mimedx
  • 市場参入企業の分類
  • 公開会社
    • イノベーター
    • マーケットリーダー
    • 企業の市況分析
    • シナジー分析：主要取引と戦略的提携
  • 非公開会社
    • 非公開会社のリスト
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of the key regulations, directives by countries
  • Table 3 List of private companies
  • Table 4 North America orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 6 North America orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 7 North America orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 10 U.S. orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 11 U.S. orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Canada orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 14 Canada orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Europe orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 18 Europe orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 19 Europe orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 20 UK orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 21 UK orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 22 UK orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 23 UK orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Germany orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 25 Germany orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 26 Germany orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 27 Germany orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 28 France orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 29 France orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 30 France orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 31 France orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 34 Italy orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 37 Spain orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 38 Spain orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 39 Spain orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Japan orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 46 Japan orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 47 Japan orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 48 China orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 49 China orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 50 China orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 51 China orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 52 India orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 53 India orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 54 India orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 55 India orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Australia orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 58 Australia orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 59 Australia orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 60 South Korea orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 61 South Korea orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 62 South Korea orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 63 South Korea orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Latin America orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 65 Latin America orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 66 Latin America orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Brazil orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 70 Brazil orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 71 Brazil orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Mexico orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 73 Mexico orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 74 Mexico orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 75 Mexico orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 78 Argentina orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 79 Argentina orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 80 MEA orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 81 MEA orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 82 MEA orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 83 MEA orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 84 South Africa orthopedic regenerative surgical products market, by component, 2018 - 2030 (USD Million)
  • Table 85 South Africa orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 86 South Africa orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 87 South Africa orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 88 South Africa orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia orthopedic regenerative surgical products market, by product, 2018 - 2030 (USD Million)
  • Table 90 Saudi Arabia orthopedic regenerative surgical products market, by allografts, 2018 - 2030 (USD Million)
  • Table 91 Saudi Arabia orthopedic regenerative surgical products market, by application, 2018 - 2030 (USD Million)
  • Table 92 Saudi Arabia orthopedic regenerative surgical products market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Orthopedic Regenerative Surgical Products market segmentation
  • Fig. 2 Methodology
  • Fig. 3 Market research process
  • Fig. 4 Data triangulation techniques
  • Fig. 5 Primary research pattern
  • Fig. 6 Primary research pattern
  • Fig. 7 Market research approaches
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modeling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Orthopedic Regenerative Surgical Products Market outlook (2022, USD Million)
  • Fig. 12 Parent market analysis
  • Fig. 13 Ancillary market analysis
  • Fig. 14 Orthopedic regenerative surgical products market dynamics analysis
  • Fig. 15 Orthopedic regenerative surgical products market driver analysis
  • Fig. 16 Common causes of spinal injury, 2018
  • Fig. 17 Orthopedic regenerative surgical products market restraint impact
  • Fig. 18 Penetration & growth prospect mapping by end-use, 2022
  • Fig. 19 Ortho regenerative technologies: Product pipeline analysis
  • Fig. 20 COVID-19 confirmed cases around the world
  • Fig. 21 Orthopedic Regenerative Surgical Products market: Product movement analysis
  • Fig. 22 Orthopedic Regenerative Surgical Products market product outlook: Key takeaways
  • Fig. 23 Allograft market, 2018 - 2030 (USD Million)
  • Fig. 24 Amniotic products market, 2018 - 2030 (USD Million)
  • Fig. 25 Others market, 2018 - 2030 (USD Million)
  • Fig. 26 Synthetic market, 2018 - 2030 (USD Million)
  • Fig. 27 Cell-based market, 2018 - 2030 (USD Million)
  • Fig. 28 Viscosupplement market, 2018 - 2030 (USD Million)
  • Fig. 29 Orthopedic Regenerative Surgical Products market: Application movement analysis
  • Fig. 30 Orthopedic Regenerative Surgical Products market application outlook: Key takeaways
  • Fig. 31 Global orthopedic pain management market, 2018 - 2030 (USD Million)
  • Fig. 32 Global trauma market, 2018 - 2030 (USD Million)
  • Fig. 33 Global cartilage and tendon repair market, 2018 - 2030 (USD Million)
  • Fig. 34 Global joint reconstruction market, 2018 - 2030 (USD million)
  • Fig. 35 Global others market, 2018 - 2030 (USD Million)
  • Fig. 36 Orthopedic Regenerative Surgical Products market: End-use movement analysis
  • Fig. 37 Orthopedic Regenerative Surgical Products market end-use outlook: Key takeaways
  • Fig. 38 Global hospitals market, 2018 - 2030 (USD Million)
  • Fig. 39 Global ambulatory surgery center market, 2018 - 2030 (USD Million)
  • Fig. 40 Global others market, 2018 - 2030 (USD Million)
  • Fig. 41 Regional outlook, 2022 & 2030
  • Fig. 42 Regional marketplace: Key takeaways
  • Fig. 43 North America orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 46 Europe orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 47 UK orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 48 Germany orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 49 France orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 51 Spain orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 54 China orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 55 India orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 56 Australia orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 60 Mexico Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 61 Argentina Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 62 MEA Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • Fig. 65 Market participant categorization
  • Fig. 66 Orthopedic regenerative surgical products: Company market position analysis
  • Fig. 67 Strategy mapping
目次
Product Code: GVR-4-68039-477-3

Orthopedic Regenerative Surgical Products Market Growth & Trends

The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.63 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at an attractive CAGR of 4.0% from 2023 to 2030. The primary factors boosting the market growth include the growing older population, easy availability of orthopedic treatments & procedures, and technological advancements. For instance, osteoarthritis, an orthopedic ailment, has been considered the major factor of chronic disability in the geriatric population (aged above 70 years). The product demand was reduced during the COVID-19 pandemic owing to the low volume of patient flow for chronic ailments in hospitals & clinics, abated marketing & sales activities, postponed elective surgeries, social distancing, and lockdown protocols.

For example, Anika Therapeutics notified challenges in patient enrollment for its clinical trials owing to the pandemic, which adversely impacted the company's operating results and revenue. However, the company recovered financial performance and operations as elective surgeries restarted post-pandemic. As per the Centers for Disease Control and Prevention (CDC), approximately 78 million adults in the U.S., or 26% of the population, are projected to be diagnosed with arthritis by 2040. The risk of arthritis increases with age and is found to be more common in females. Another risk factor is obesity. According to the CDC, the prevalence of obesity in the U.S. was estimated to be around 42.4% from 2017 to 2018. Thus, the growing prevalence of orthopedic ailments and the rising aging population & obesity cases are expected to drive market growth. The products used in orthopedic regenerative surgery have a wide range of applications, including gout, joint pain, fibromyalgia, articular defects, osteoarthritis, joint replacement, and trauma.

This is also anticipated to contribute to the growth of the market. Key players in the market are involved in several strategic initiatives, including R&D projects to introduce new regenerative solutions for pain relief from diseases. For instance, in March 2021, Amniox Medical, Inc., received FDA clearance to proceed with a dosing study using its Investigational New Drug (IND) TTAX03- consisting of the umbilical cord and cryopreserved amniotic membrane, to alleviate facet joint osteoarthritis pain. The market participants offer a wide range of orthopedic products; for instance, Zimmer Biomet provides a wide portfolio of synthetic orthopedic regenerative products and allografts, such as the InterGro DBM, PrimaGen Advanced allograft, and PlatFORM bioresorbable bone graft substitute.

Orthopedic Regenerative Surgical Products Market Report Highlights

  • The viscosupplements segment held the largest market share of about 42.59% in 2022 owing to the high prevalence of orthopedic conditions, such as osteoarthritis, and increasing product availability in the market
  • The allografts segment is anticipated to witness a CAGR of 4.1% during the forecast period owing to the increasing utilization of allografts
  • The joint reconstruction segment held the largest revenue share of 35.66% in 2022 in the application segment due to the rising adoption of regenerative solutions in joint reconstruction
  • The cartilage & tendon repair segment is estimated to grow at the fastest CAGR of 4.2% during the forecast period owing to increasing applications in geriatric patients and sports medicine
  • The hospital end-use segment dominated the market and held the largest revenue share of about 49.04% in 2022 as most orthopedic treatments are performed in hospital settings
  • The ambulatory surgical centers (ASCs) segment is expected to showcase the fastest CAGR of 4.1% during the forecast period
  • Key players in the market are undertaking various strategic initiatives, including product development & launches, R&D, regional expansion, and distribution network expansion
  • In January 2021, Stryker acquired OrthoSensor, Inc., a private company that specializes in sensor technology and musculoskeletal care

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Segment Scope
    • 1.1.2 Regional Scope
    • 1.1.3 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Research Assumptions
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
    • 1.4.5 Details Of Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Market Formulation & Validation
    • 1.5.2 Data Analysis Models
  • 1.6 Market Formulation & Validation
    • 1.6.1 Primary Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
  • 1.8 List Of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Orthopedic Regenerative Surgical Products Market Summary

Chapter 3 Orthopedic Regenerative Surgical Products Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Analysis
    • 3.1.2 Ancillary Market Analysis
  • 3.2 Orthopedic Regenerative Surgical Products Market Dynamics
    • 3.2.1 Market Driver Analysis
    • 3.2.2 Market Restraint Analysis
    • 3.2.3 Market Opportunity Analysis
    • 3.2.4 Market Challenge Analysis
  • 3.3 Penetration And Growth Prospect Mapping,2022
  • 3.4 Swot Analysis, By Factor (Political & Legal, Economic And Technological)
    • 3.4.1 Political & Legal
    • 3.4.2 Economic Landscape
    • 3.4.3 Technology Landscape
  • 3.5 Orthopedic Regenerative Surgical Products Market Analysis Tools: Porters
    • 3.5.1 Bargaining Power Of Suppliers: Low To Moderate
    • 3.5.2 Bargaining Power Of Buyers: Moderate
    • 3.5.3 Threat Of Substitutes: High
  • 3.6 Regulatory Framework
    • 3.6.1 Fda Consideration
    • 3.6.2 Reimbursement Framework
    • 3.6.3 Hcpcs Coding
  • 3.7 Technology Trend Analysis
  • 3.8 Product Pipeline Analysis
  • 3.9 Osteoarthritis Prevalence (2018 to 2030)

Chapter 4 Orthopedic Regenerative Surgical Products Market: COVID-19 Impact Analysis

  • 4.1 COVID-19 Impact Analysis
    • 4.1.1 Disease Prevalence Analysis
    • 4.1.2 Current Impact Analysis
    • 4.1.3 Future Impact Analysis
    • 4.1.4 Impact On Market Players

Chapter 5 Orthopedic Regenerative Surgical Products Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 5.1 Product Market Share Analysis,2022 & 2030
  • 5.2 Orthopedic Regenerative Surgical Products Market, by Product, 2018 to 2030
  • 5.3 Allograft
    • 5.3.1 Allograft Market, 2018 - 2030 (USD Million)
      • 5.3.1.1 Amniotic Products
      • 5.3.1.1.1 Amniotic Products Market, 2018 - 2030 (USD Million)
    • 5.3.2 Others
      • 5.3.2.1 Others Market, 2018 - 2030 (USD Million)
  • 5.4 Synthetic
    • 5.4.1 Synthetic Market, 2018 - 2030 (USD Million)
  • 5.5 Cell-Based
    • 5.5.1 Cell-Based Market, 2018 - 2030 (USD Million)
  • 5.6 Viscosupplement
    • 5.6.1 Viscosupplement Market, 2018 - 2030 (USD Million)

Chapter 6 Orthopedic Regenerative Surgical Products Market Analysis, By Application, 2018 - 2030 (Revenue, USD Million)

  • 6.1 Application Market Share Analysis,2022 & 2030
  • 6.2 Orthopedic Regenerative Surgical Products Market, By Application, 2018 To 2030
  • 6.3 Orthopedic Pain Management
    • 6.3.1 Orthopedic Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Trauma Repair
    • 6.4.1 Trauma Repair Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5 Cartilage And Tendon Repair
    • 6.5.1 Cartilage And Tendon Repair Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6 Joint Reconstruction
    • 6.6.1 Joint Reconstruction Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7 Others
    • 6.7.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7 Orthopedic Regenerative Surgical Products Market: Segment Analysis, By End-Use, 2018 - 2030 (USD Million)

  • 7.1 End-Use Market Share Analysis, 2022 & 2030
  • 7.2 Orthopedic Regenerative Surgical Products Market, By End-Use, 2018 To 2030
  • 7.3 Hospitals
    • 7.3.1 Hospitals Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.4 Ambulatory Surgery Centers
    • 7.4.1 Ambulatory Surgery Center Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.5 Others
    • 7.5.1 Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8 Orthopedic Regenerative Surgical Products Market: Regional Market Analysis 2018 - 2030 (USD Million)

  • 8.1 Regional Market Share Analysis, 2022 & 2030
  • 8.2 Regional Market Snapshot
  • 8.3 North America
    • 8.3.1 North America orthopedic regenerative surgical products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.3.2 U.S.
      • 8.3.2.1 U.S. orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.3.3 Canada
      • 8.3.3.1 Canada Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • 8.4 Europe
    • 8.4.1 Europe orthopedic regenerative surgical products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.4.2 UK
      • 8.4.2.1 UK orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.3 Germany
      • 8.4.3.1 Germany orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.4 France
      • 8.4.4.1 France orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.5 Italy
      • 8.4.5.1 Italy orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.4.6 Spain
      • 8.4.6.1 Spain orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • 8.5 Asia Pacific
    • 8.5.1 Asia Pacific orthopedic regenerative surgical products market estimates and forecasts, 2018 - 2030 (USD Million)
    • 8.5.2 Japan
      • 8.5.2.1 Japan orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.3 China
      • 8.5.3.1 China orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.4 India
      • 8.5.4.1 India orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.5 Australia
      • 8.5.5.1 Australia orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.5.5 South Korea
      • 8.5.4.1 South Korea orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
  • 8.6 Latin America
    • 8.6.1 Latin America orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.6.2 Brazil
      • 8.6.2.1 Brazil Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
    • 8.6.3 Mexico
      • 8.6.3.1 Mexico orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.6.4 Argentina
      • 8.6.4.1 Argentina Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
  • 8.7 MEA
    • 8.7.1 MEA orthopedic regenerative surgical products market, 2018 - 2030 (USD Million)
    • 8.7.2 South Africa
      • 8.7.2.1 South Africa Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)
    • 8.7.3 Saudi Arabia
      • 8.7.3.1 Saudi Arabia Orthopedic Regenerative Surgical Products market, 2018 - 2030 (USD Million)

Chapter 9 Orthopedic Regenerative Surgical Products Market - Company Profiles

  • 9.1 Company Profiles
    • 9.1.1 Baxter
      • 9.1.1.1 Company Overview
      • 9.1.1.2 Financial Performance
      • 9.1.1.3 Product Benchmarking
      • 9.1.1.4 Strategic Initiatives
    • 9.1.2 Zimmer Biomet
      • 9.1.2.1 Company Overview
      • 9.1.2.2 Financial Performance
      • 9.1.2.3 Product Benchmarking
      • 9.1.2.4 Strategic Initiatives
    • 9.1.3 Stryker
      • 9.1.3.1 Company Overview
      • 9.1.3.2 Financial Performance
      • 9.1.3.3 Product Benchmarking
      • 9.1.3.4 Strategic Initiatives
    • 9.1.4 Smith+Nephew
      • 9.1.4.1 Company Overview
      • 9.1.4.2 Financial Performance
      • 9.1.4.3 Product Benchmarking
      • 9.1.4.4 Strategic Initiatives
    • 9.1.5 Allosource
      • 9.1.5.1 Company Overview
      • 9.1.5.2 Financial Performance
      • 9.1.5.3 Product Benchmarking
      • 9.1.5.4 Strategic Initiatives
    • 9.1.6 Amniox Medical, Inc.
      • 9.1.6.1 Company Overview
      • 9.1.6.2 Financial Performance
      • 9.1.6.3 Product Benchmarking
      • 9.1.6.4 Strategic Initiatives
    • 9.1.7 Anika Therapeutics, Inc.
      • 9.1.7.1 Company Overview
      • 9.1.7.2 Financial Performance
      • 9.1.7.3 Product Benchmarking
      • 9.1.7.4 Strategic Initiatives
    • 9.1.8 Vericel Corporation
      • 9.1.8.1 Company Overview
      • 9.1.8.2 Financial Performance
      • 9.1.8.3 Product Benchmarking
      • 9.1.8.4 Strategic Initiatives
    • 9.1.9 Vsy Biotechnology Gmbh
      • 9.1.9.1 Company Overview
      • 9.1.9.2 Financial Performance
      • 9.1.9.3 Product Benchmarking
      • 9.1.9.4 Strategic Initiatives
    • 9.1.10 Aptissen S.A
      • 9.1.10.1 Company Overview
      • 9.1.10.2 Financial Performance
      • 9.1.10.3 Product Benchmarking
      • 9.1.10.4 Strategic Initiatives
    • 9.1.11 Mimedx
      • 9.1.11.1 Company Overview
      • 9.1.11.2 Financial Performance
      • 9.1.11.3 Product Benchmarking
      • 9.1.11.4 Strategic Initiatives
  • 9.2 Market Participant Categorization
  • 9.3 Public Companies
    • 9.3.1 Innovators
    • 9.3.2 Market Leaders
    • 9.3.3 Company Market Position Analysis
    • 9.3.4 Synergy Analysis: Major Deals & Strategic Alliances
  • 9.4 Private Companies
    • 9.4.1 List Of Private Companies